Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0015000LC2
Wed, 15.03.2023
Mainz BioMed N.V.
Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
Labor Staber to actively market and sell ColoAlert to its physician and patient network.
BERKELEY, US – MAINZ, Germany – [March 15, 2023] — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company s [ … ]
Wed, 15.03.2023
Mainz BioMed N.V.
Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
Labor Staber to actively market and sell ColoAlert to its physician and patient network.
BERKELEY, US – MAINZ, Germany – [March 15, 2023] — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company s [ … ]
Wed, 08.03.2023
Mainz BioMed N.V.
Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection
Sponsor of Gastro Update 2023, 2-day scientific and training events for gastroenterology professionals
Patient Education Day in the City of Mainz, Germany, where the Company is headquartered
Germany-based molecular diagnostic s [ … ]
Wed, 08.03.2023
Mainz BioMed N.V.
Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection
Sponsor of Gastro Update 2023, 2-day scientific and training events for gastroenterology professionals
Patient Education Day in the City of Mainz, Germany, where the Company is headquartered
Germany-based molecular diagnostic s [ … ]
Wed, 01.03.2023
Mainz BioMed N.V.
Mainz Biomed Recognizes Colorectal Cancer Awareness Month Throughout “Blue” March 2023
Mainz Biomed to host several events for patients and healthcare professionals in Germany to increase awareness about the importance of early detection of colorectal cancer.
BERKELEY, US – MAINZ, Germany – March 1, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Main [ … ]
Wed, 01.03.2023
Mainz BioMed N.V.
Mainz Biomed Recognizes Colorectal Cancer Awareness Month Throughout “Blue” March 2023
Mainz Biomed to host several events for patients and healthcare professionals in Germany to increase awareness about the importance of early detection of colorectal cancer.
BERKELEY, US – MAINZ, Germany – March 1, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Main [ … ]